
🚀A new study by our team explores clinician perspectives on #asynchronouscare for ovarian cancer patients on PARPi therapy
Findings highlight considerations like safety, patient preference, and willingness to innovate
👀bit.ly/4j6w0ik
@pmcancercentre @PMResearch_UHN
English






